Navigation Links
Catherine Sohn Elected To Jazz Pharmaceuticals Board Of Directors
Date:7/30/2012

DUBLIN, July 30, 2012 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the election of Catherine Angell Sohn, Pharm.D., CLP, to its board of directors at the company's annual meeting of shareholders held on July 27, 2012.

"Cathy has extensive product and business development experience and brings a strong patient-focused perspective to our board," said Bruce Cozadd, chairman and chief executive officer of Jazz Pharmaceuticals.  "As we strengthen our operations in both the United States and Europe, continue to optimize our commercial activities and evaluate product development strategies for the future, Cathy will add tremendous value."

Catherine Angell Sohn, Pharm.D., CLP, is the founder of Sohn Health Strategies where she consults for pharmaceutical, biotechnology, medical device, and consumer healthcare companies in the areas of business strategy, business development and strategic product development. She currently serves on the boards of Ariel Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, and The Dohmen Company, a privately held provider of business services to life science companies. She also serves on the Dean's Advisory Council for Drexel University School of Public Health, the Ben Franklin Technology Partners Investment Advisory Committee, Ernst & Young's global Life Science Advisory Board, Springboard Enterprises Life Science Council and the global advisory board of the Healthcare Businesswomen's Association. 

From 1982 to 2010, Dr. Sohn was with GlaxoSmithKline plc (and with SmithKline Beecham plc before its merger with GlaxoWellcome plc), where she served most recently as senior vice president, worldwide business development and strategic alliances in the GSK Consumer Healthcare division.  Previously, she held a series of positions in medical affairs, pharmaceutical business development, U.S. product marketing, and global strategic product development in the pharmaceutical division.  She also previously served on the boards of multiple non-profit organizations, including two terms on the Health Advisory Board for the Johns Hopkins University Bloomberg School of Public Health and as vice chair of the Corporate Executive Board of the Philadelphia Museum of Art.

Dr. Sohn started her career as Assistant Professor of Clinical Pharmacy at the University of the Sciences in Philadelphia, where she currently holds the position of Dean's Professor. She received a Pharm.D. from the University of California, San Francisco, School of Pharmacy. She also received a Certificate of Professional Development from The Wharton School at the University of Pennsylvania.

About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing products that address unmet medical needs. The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain, psychiatry and women's health. The company's U.S. marketed products in these areas include: Xyrem® (sodium oxybate), Erwinaze™ (asparaginase Erwinia chrysanthemi), Prialt® (ziconotide intrathecal infusion), FazaClo® (clozapine USP) HD and LD, Luvox CR® (fluvoxamine maleate) and Elestrin® (estradiol gel 0.06%). Outside of the U.S., Jazz Pharmaceuticals also has a number of products marketed by an international division, EUSA Pharma.


'/>"/>
SOURCE Jazz Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Bench International Adds Catherine Balin to Executive Team
2. Remedy Informatics Cardiovascular Registry Selected by World-Renowned Cleveland Clinic Heart and Vascular Institute
3. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
4. Elsevier Selected as New Publisher of The American Journal of Geriatric Psychiatry
5. DICOM Grid Selected as a Finalist for the 2012 Red Herring Top 100 Americas Award
6. Centene Corporation Selected for Ohio Medicaid Contract
7. Bench Internationals Denise (DeeDee) DeMan Elected to SoCalBios Board of Directors
8. Sterne, Kessler, Goldstein & Fox Selected by 15 Year Old Winner of Intel International Science and Engineering Fair
9. Nature Made Selected As "Top Recommended Health Product" By U.S. News & World Report And Pharmacy Times
10. ApolloMed ACO Selected To Participate In A Transformative New Initiative Sponsored by the Centers for Medicare and Medicaid Services
11. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
(Date:4/18/2017)... April 18, 2017 Research and Markets has ... report to their offering. ... The global arthroscopy devices market to grow at a CAGR of ... Arthroscopy Devices Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
Breaking Medicine Technology:
(Date:4/26/2017)... , ... April 26, 2017 , ... ... to improve the profitability of ready-to-drink, high-protein beverages by helping beverage manufacturers more ... to dairy proteins, providing direct cost savings as well as more stable pricing ...
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical Therapy (PRPT) ... preferred physical therapy provider for Derby City CrossFit, effective immediately. , In addition ... quickly and effectively as possible, ProRehab’s sports physical therapists will work with athletes ...
(Date:4/25/2017)... ... ... The doctors at Wall Centre Dental are now expanding their practice by accepting ... receive dental care. The doctors offer three treatment options to put victims of ... at their dental office in Vancouver. Wall Centre Dental is currently welcoming even patients ...
(Date:4/25/2017)... GA (PRWEB) , ... April 25, 2017 , ... ... their neck and back pain with a reputable physician in their area, announces the ... CRM protects patient information for patients who are looking for reputable physicians to help ...
(Date:4/25/2017)... Fl (PRWEB) , ... April 25, 2017 , ... There ... Memorial Regional Hospital, according to a special report in the May issue of Consumer ... its highest quality ranking for results achieved during and after coronary bypass and ...
Breaking Medicine News(10 mins):